Discontinuation for Oral Anticoagulants in Patients With Atrial Fibrillation

Anticoagulant Drugs Clinical Trial

Official title:
Discontinuation for Oral Anticoagulants During the First Year of Use in Patients With Atrial Fibrillation Covered by a Medical Insurance

Status Active, not recruiting

Clinical Trial Summary

The purpose of this study is to compare the discontinuation rates for vitamin K antagonists and for direct oral anticoagulants during their first year

Clinical Trial Description

The purpose of this study is to compare the discontinuation rates for vitamin K antagonists and for direct oral anticoagulants during their first year of use after their initiation during hospitalization in patients covered by our health insurance plan. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04133545
Study type	Observational
Source	Hospital Italiano de Buenos Aires
Contact
Status	Active, not recruiting
Phase
Start date	April 4, 2018
Completion date	September 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03188211` - E-learning to Improve Oral Anticoagulant Use in Hospitalized Older People With AF	N/A
Recruiting	`NCT03753568` - Effect of an Electronic Reminder System on Direct Oral Anticoagulant and Oral Diabetes Medication Adherence	N/A
Recruiting	`NCT05416190` - Effect of Injectable Anticoagulants on Research for a Circulating Lupus-type Anticoagulant	N/A
Recruiting	`NCT05852197` - Effect of Anticoagulant Drug Intervention on Postoperative MALE and MACE in Patients With PAD
Completed	`NCT02898090` - Development and Validation of Automated Indicators on the Appropriateness of Oral Anticoagulant Prescriptions